Overview

Delayed Start to Ovarian Stimulation

Status:
Terminated

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

In couples with infertility secondary to Diminished Ovarian Reserve, the investigators hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist (Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, San Francisco

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Ganirelix